Cargando…

Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer

BACKGROUND: The relationship between the clinicopathological features and molecular changes associated with standardized uptake value (SUV) determined by Positron emission tomography (PET) with [18F] fluorodeoxyglucose (18F-FDG PET) in human renal cell carcinoma (RCC) has not been elucidated. On the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Tomoya, Kamai, Takao, Abe, Hideyuki, Sakamoto, Setsu, Kitajima, Kazuhiro, Nishihara, Daisaku, Yuki, Hideo, Kambara, Tsunehito, Betsunoh, Hironori, Yashi, Masahiro, Fukabori, Yoshitatsu, Kaji, Yasushi, Yoshida, Ken-Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357069/
https://www.ncbi.nlm.nih.gov/pubmed/25784113
http://dx.doi.org/10.1186/s12885-015-1097-0
_version_ 1782361086206410752
author Mizuno, Tomoya
Kamai, Takao
Abe, Hideyuki
Sakamoto, Setsu
Kitajima, Kazuhiro
Nishihara, Daisaku
Yuki, Hideo
Kambara, Tsunehito
Betsunoh, Hironori
Yashi, Masahiro
Fukabori, Yoshitatsu
Kaji, Yasushi
Yoshida, Ken-Ichiro
author_facet Mizuno, Tomoya
Kamai, Takao
Abe, Hideyuki
Sakamoto, Setsu
Kitajima, Kazuhiro
Nishihara, Daisaku
Yuki, Hideo
Kambara, Tsunehito
Betsunoh, Hironori
Yashi, Masahiro
Fukabori, Yoshitatsu
Kaji, Yasushi
Yoshida, Ken-Ichiro
author_sort Mizuno, Tomoya
collection PubMed
description BACKGROUND: The relationship between the clinicopathological features and molecular changes associated with standardized uptake value (SUV) determined by Positron emission tomography (PET) with [18F] fluorodeoxyglucose (18F-FDG PET) in human renal cell carcinoma (RCC) has not been elucidated. On the other hand, overactivation of the phosphatidylinositol 3’kinase (PI3K), serine/threonine kinase Akt, and mammalian target of rapamycin (mTOR) pathway has been detected in a variety of human cancers, including RCC. So far, little is known about the relationship between the SUV and these proteins in human RCC. Thus, it is important to study the relevance of SUV with clinicopathological features in human RCCs from a molecular point of view. METHODS: Seventy-seven consecutive patients with RCC who underwent nephrectomy and pretreatment determination of the maximum SUV (SUVmax) by 18F-FDG PET were analyzed. We investigated the relationship between the SUVmax, phosphorylated-Akt (Ser-473) (pAkt(Ser-473)), phosphorylated-Akt (Thr-308) (pAkt(Thr-308), and phosphorylated-S6 ribosomal protein (Ser-235/236) (pS6) protein levels in the primary tumor and various clinicopathological features. RESULTS: The average SUVmax of the primary tumor was 6.9 (1.5 to 40.3). A higher SUVmax was correlated with higher expression of pAkt(Ser-473), pAkt (Thr-308), and pS6 protein in the primary tumor. A higher SUVmax and increased expression of pAkt (Ser-473), pAkt (Thr-308), and pS6 of the primary tumor was associated with less tumor differentiation, a higher pT stage, regional lymph node involvement, microscopic vascular invasion, and distant metastasis, as well as with early relapse following radical nephrectomy in patients who had localized or locally advanced RCC without distant metastasis (cTanyNanyM0) and with shorter overall survival in all patients. CONCLUSIONS: A higher SUVmax on 18F-FDG PET is associated with elevated tumor levels of pAkt and pS6 protein and with aggressive behavior and metastatic potential of RCC, as well as with early relapse following radical nephrectomy and shorter overall survival. These findings suggest that SUVmax may be useful for predicting the biological characteristics of RCC.
format Online
Article
Text
id pubmed-4357069
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43570692015-03-13 Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer Mizuno, Tomoya Kamai, Takao Abe, Hideyuki Sakamoto, Setsu Kitajima, Kazuhiro Nishihara, Daisaku Yuki, Hideo Kambara, Tsunehito Betsunoh, Hironori Yashi, Masahiro Fukabori, Yoshitatsu Kaji, Yasushi Yoshida, Ken-Ichiro BMC Cancer Research Article BACKGROUND: The relationship between the clinicopathological features and molecular changes associated with standardized uptake value (SUV) determined by Positron emission tomography (PET) with [18F] fluorodeoxyglucose (18F-FDG PET) in human renal cell carcinoma (RCC) has not been elucidated. On the other hand, overactivation of the phosphatidylinositol 3’kinase (PI3K), serine/threonine kinase Akt, and mammalian target of rapamycin (mTOR) pathway has been detected in a variety of human cancers, including RCC. So far, little is known about the relationship between the SUV and these proteins in human RCC. Thus, it is important to study the relevance of SUV with clinicopathological features in human RCCs from a molecular point of view. METHODS: Seventy-seven consecutive patients with RCC who underwent nephrectomy and pretreatment determination of the maximum SUV (SUVmax) by 18F-FDG PET were analyzed. We investigated the relationship between the SUVmax, phosphorylated-Akt (Ser-473) (pAkt(Ser-473)), phosphorylated-Akt (Thr-308) (pAkt(Thr-308), and phosphorylated-S6 ribosomal protein (Ser-235/236) (pS6) protein levels in the primary tumor and various clinicopathological features. RESULTS: The average SUVmax of the primary tumor was 6.9 (1.5 to 40.3). A higher SUVmax was correlated with higher expression of pAkt(Ser-473), pAkt (Thr-308), and pS6 protein in the primary tumor. A higher SUVmax and increased expression of pAkt (Ser-473), pAkt (Thr-308), and pS6 of the primary tumor was associated with less tumor differentiation, a higher pT stage, regional lymph node involvement, microscopic vascular invasion, and distant metastasis, as well as with early relapse following radical nephrectomy in patients who had localized or locally advanced RCC without distant metastasis (cTanyNanyM0) and with shorter overall survival in all patients. CONCLUSIONS: A higher SUVmax on 18F-FDG PET is associated with elevated tumor levels of pAkt and pS6 protein and with aggressive behavior and metastatic potential of RCC, as well as with early relapse following radical nephrectomy and shorter overall survival. These findings suggest that SUVmax may be useful for predicting the biological characteristics of RCC. BioMed Central 2015-03-10 /pmc/articles/PMC4357069/ /pubmed/25784113 http://dx.doi.org/10.1186/s12885-015-1097-0 Text en © Mizuno et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mizuno, Tomoya
Kamai, Takao
Abe, Hideyuki
Sakamoto, Setsu
Kitajima, Kazuhiro
Nishihara, Daisaku
Yuki, Hideo
Kambara, Tsunehito
Betsunoh, Hironori
Yashi, Masahiro
Fukabori, Yoshitatsu
Kaji, Yasushi
Yoshida, Ken-Ichiro
Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
title Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
title_full Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
title_fullStr Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
title_full_unstemmed Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
title_short Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
title_sort clinically significant association between the maximum standardized uptake value on (18)f-fdg pet and expression of phosphorylated akt and s6 kinase for prediction of the biological characteristics of renal cell cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357069/
https://www.ncbi.nlm.nih.gov/pubmed/25784113
http://dx.doi.org/10.1186/s12885-015-1097-0
work_keys_str_mv AT mizunotomoya clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT kamaitakao clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT abehideyuki clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT sakamotosetsu clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT kitajimakazuhiro clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT nishiharadaisaku clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT yukihideo clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT kambaratsunehito clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT betsunohhironori clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT yashimasahiro clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT fukaboriyoshitatsu clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT kajiyasushi clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer
AT yoshidakenichiro clinicallysignificantassociationbetweenthemaximumstandardizeduptakevalueon18ffdgpetandexpressionofphosphorylatedaktands6kinaseforpredictionofthebiologicalcharacteristicsofrenalcellcancer